{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T05:24:50.811534+00:00","company":{"ticker":"YBGJ","cik":895464,"company_name":"Yubo International Biotech Ltd"},"pagination":{"limit":100,"returned":6,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"auditor_change","fact_key":"f176b686231b6872e7f55a9ee84edcb8262d1c36","cik":895464,"ticker":"YBGJ","company_name":"Yubo International Biotech Ltd","filed_at":"2026-01-16T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"HCL, PLLC","disagreement_text":null,"effective_date":"2026-01-13","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Yubo International Biotech Ltd engaged HCL, PLLC as its auditor.","evidence_excerpt":"On January 13, 2026, the Company engaged HCL, PLLC (“HCL”) as its new independent registered public accountant to audit the Company’s consolidated financial statements for the year ended December 31, 2025, with immediate effect.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001640334-26-000105","anchor_url":"https://secwatch.observer/filing/0001640334-26-000105#claim-f176b686231b6872e7f55a9ee84edcb8262d1c36","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/895464/000164033426000105/0001640334-26-000105-index.htm"},{"fact_type":"auditor_change","fact_key":"23a4a76bfaa71f8208d307b227898ae8ca06ee5c","cik":895464,"ticker":"YBGJ","company_name":"Yubo International Biotech Ltd","filed_at":"2026-01-16T23:59:59+00:00","payload":{"action":"resignation","auditor_name":"HHL LLP","disagreement_text":null,"effective_date":"2026-01-13","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"HHL LLP resigned as auditor of Yubo International Biotech Ltd.","evidence_excerpt":"On January 13, 2026, HHL LLP (“HHL”) tendered its resignation as the independent registered public accounting firm to Yubo International Biotech Limited","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001640334-26-000105","anchor_url":"https://secwatch.observer/filing/0001640334-26-000105#claim-23a4a76bfaa71f8208d307b227898ae8ca06ee5c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/895464/000164033426000105/0001640334-26-000105-index.htm"},{"fact_type":"auditor_change","fact_key":"27b2f58ed4937a7d068e65fb6181635b2a5869a0","cik":895464,"ticker":"YBGJ","company_name":"Yubo International Biotech Ltd","filed_at":"2025-01-10T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"HHL LLP","disagreement_text":null,"effective_date":"2025-01-02","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Yubo International Biotech Ltd engaged HHL LLP as its auditor.","evidence_excerpt":"On December 30, 2024, the Company engaged HHL LLP (“HHL”) as its new independent registered public accountant, effective January 2, 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001640334-25-000050","anchor_url":"https://secwatch.observer/filing/0001640334-25-000050#claim-27b2f58ed4937a7d068e65fb6181635b2a5869a0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/895464/000164033425000050/0001640334-25-000050-index.htm"},{"fact_type":"auditor_change","fact_key":"1677eff355e862ec1afc473b64216f4975467355","cik":895464,"ticker":"YBGJ","company_name":"Yubo International Biotech Ltd","filed_at":"2025-01-10T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Michael T. Studer CPA P.C.","disagreement_text":null,"effective_date":"2025-01-02","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Yubo International Biotech Ltd dismissed Michael T. Studer CPA P.C. as its auditor.","evidence_excerpt":"On December 26, 2024, Yubo International Biotech Limited, a New York corporation (the “Company”), dismissed Michael T. Studer CPA P.C. (“MTS CPA”) as the Company’s independent registered public accounting firm","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001640334-25-000050","anchor_url":"https://secwatch.observer/filing/0001640334-25-000050#claim-1677eff355e862ec1afc473b64216f4975467355","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/895464/000164033425000050/0001640334-25-000050-index.htm"},{"fact_type":"auditor_change","fact_key":"ea57b7d9bd391ba6c6274b44e991aca0bedd990d","cik":895464,"ticker":"YBGJ","company_name":"Yubo International Biotech Ltd","filed_at":"2025-01-06T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"HHL Advisors Group","disagreement_text":null,"effective_date":"2025-01-02","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Yubo International Biotech Ltd engaged HHL Advisors Group as its auditor.","evidence_excerpt":"On December 26, 2024, the Company engaged HHL Advisors Group (“HHL”) as its new independent registered public accountant, effective January 2, 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001640334-25-000025","anchor_url":"https://secwatch.observer/filing/0001640334-25-000025#claim-ea57b7d9bd391ba6c6274b44e991aca0bedd990d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/895464/000164033425000025/0001640334-25-000025-index.htm"},{"fact_type":"auditor_change","fact_key":"55bfc6de3af41983320737ec29003f17ab133f08","cik":895464,"ticker":"YBGJ","company_name":"Yubo International Biotech Ltd","filed_at":"2025-01-06T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Michael T. Studer CPA P.C.","disagreement_text":null,"effective_date":"2025-01-02","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"HHL Advisors Group"},"claim":"Yubo International Biotech Ltd dismissed Michael T. Studer CPA P.C. as its auditor.","evidence_excerpt":"On December 26, 2024, Yubo International Biotech Limited, a New York corporation (the “Company”), dismissed Michael T. Studer CPA P.C. (“MTS CPA”) as the Company’s independent registered public accounting firm","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001640334-25-000025","anchor_url":"https://secwatch.observer/filing/0001640334-25-000025#claim-55bfc6de3af41983320737ec29003f17ab133f08","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/895464/000164033425000025/0001640334-25-000025-index.htm"}]}